These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15936477)

  • 1. [Rituximab: a original biotherapy in auto-immune disorders].
    Sibilia J; Sordet C
    Rev Med Interne; 2005 Jun; 26(6):485-500. PubMed ID: 15936477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biotherapy of auto-immune diseases : past, present and future perspectives].
    Arnaud L; Haroche J; Piette JC; Amoura Z
    Presse Med; 2009 May; 38(5):749-60. PubMed ID: 19303737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
    Perosa F; Prete M; Racanelli V; Dammacco F
    J Intern Med; 2010 Mar; 267(3):260-77. PubMed ID: 20201920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
    Pescovitz MD
    Am J Transplant; 2006 May; 6(5 Pt 1):859-66. PubMed ID: 16611321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: current status as therapy for malignant and benign hematologic disorders.
    Abdulla NE; Ninan MJ; Markowitz AB
    BioDrugs; 2012 Apr; 26(2):71-82. PubMed ID: 22339395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab and its use in autoimmune bullous disorders.
    Daniel BS; Murrell DF; Joly P
    Immunol Allergy Clin North Am; 2012 May; 32(2):331-7, viii. PubMed ID: 22560146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 monoclonal antibodies: beyond B-cells.
    Avivi I; Stroopinsky D; Katz T
    Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rituximab in treatment for neuroimmunological diseases].
    Schröder A; Ellrichmann G; Chehab G; Schneider M; Linker RA; Gold R
    Nervenarzt; 2009 Feb; 80(2):155-6, 158-60, 162-5. PubMed ID: 19183926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab: a promising therapy in systemic lupus erythematosus.
    Thatayatikom A; White AJ
    Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab and its use in autoimmune bullous disorders.
    Daniel BS; Murrell DF; Joly P
    Dermatol Clin; 2011 Oct; 29(4):571-5. PubMed ID: 21925000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of systemic autoimmune and inflammatory diseases with rituximab].
    Bussone G; Hachulla E; Sibilia J; Michel M; Godeau B; Guillevin L; Mouthon L
    Presse Med; 2009 May; 38(5):808-23. PubMed ID: 19297127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is B-cell depletion still a good strategy for treating immune thrombocytopenia?
    Godeau B; Stasi R
    Presse Med; 2014 Apr; 43(4 Pt 2):e79-85. PubMed ID: 24636845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rationale and clinical evidence for the use of rituximab in glomerular diseases].
    Mani LY; Vogt B; Burnier M; Golshayan D
    Rev Med Suisse; 2011 Apr; 7(290):819-24. PubMed ID: 21595313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights.
    Silverman GJ
    Front Biosci; 2007 Jan; 12():2194-206. PubMed ID: 17127456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab therapy for autoimmune haematological diseases.
    Barcellini W; Zanella A
    Eur J Intern Med; 2011 Jun; 22(3):220-9. PubMed ID: 21570637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.